🔍

Unjha Formulations Ltd (531762)

📊 BSE: 531762 🏢 Pharmaceuticals 📢 Latest filing: 14 Aug 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Unjha Formulations' revenue was ₹3.3 Cr (-8.4% year on year, -0.7% on the previous quarter), and net profit ₹0.2 Cr (-59.8% year on year); the operating margin was 5.9%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹3.3	-8.4%	-0.7%
Operating profit	₹0.2	-51.2%	from loss
Net profit	₹0.2	-59.8%	from loss
EPS (₹)	0.35	-59.8%	from loss
Operating margin	5.9%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Unjha Formulations Shareholders Approve All Resolutions at 32nd AGM with 43.16% Turnout

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 14 Aug 2026, 07:02 PM

Unjha Formulations Limited announced the voting results for its 32nd Annual General Meeting held on 14th August 2026. A total of 19,33,616 votes were cast across 4,480,500 total shares, representing a 43.16% voter turnout. Key resolutions approved included the adoption of FY26 financial statements, approval of related party transactions for FY 2026-27, and the appointment of Smt. Krutiben S Patel as Managing Director with 92.79% approval.

Overall voter turnout stood at 43.16% (19,33,616 votes cast out of 4,480,500 total shares)
Appointment of Smt. Krutiben S Patel as Managing Director approved with 92.79% votes in favour (17,94,283 votes)
Related party transactions for FY 2026-27 approved with 100% votes in favour (19,33,616 votes)
Total shareholder count stood at 4,435 as on the cut-off date

💡 Track subsequent quarterly financial performances and operational execution under the confirmed management.

Unjha Formulations Submits FY26 Cash Flow Statement Post 32nd AGM

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Aug 2026, 06:43 PM

Unjha Formulations submitted its audited Cash Flow Statement for the financial year ended March 31, 2026, following its 32nd Annual General Meeting held on August 14, 2026. The company reported net cash inflow from operating activities of 124.38 (in Lakhs/stated units) for FY26, recovering from a net outflow of 4.49 in FY25. Cash and cash equivalents increased to 164.48 at the end of FY26 compared to 64.38 at the end of FY25. Capex for purchase of fixed assets stood at 23.49 for FY26 compared to 18.09 in FY25.

32nd Annual General Meeting conducted on August 14, 2026 at the registered office in Sidhpur.
Net cash inflow from operating activities reached 124.38 for FY26 versus an outflow of 4.49 in FY25.
Cash used in purchase of fixed assets (capex) was 23.49 in FY26 compared to 18.09 in FY25.
Closing cash and cash equivalents increased to 164.48 as of March 31, 2026 from 64.38 in FY25.

💡 Track upcoming Q2 FY27 quarterly financial results and execution stability in upcoming reporting cycles.

Unjha Formulations Submits FY26 Cash Flow; Operating Cash Flow Reaches 124.38

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 14 Aug 2026, 06:39 PM

Unjha Formulations Limited submitted its audited Cash Flow Statement for the financial year ended March 31, 2026, following its 32nd Annual General Meeting held on August 14, 2026. The company reported a net cash inflow from operating activities of 124.38 for FY26, rebounding from a cash outflow of -4.49 in FY25. Net cash used in investing activities stood at -23.49 for capex (purchase of fixed assets), compared to -17.79 in the prior year. Cash and cash equivalents at the end of FY26 closed higher at 164.48 compared to 64.38 at the start of the year.

Net cash inflow from operating activities was 124.38 for FY26 versus an outflow of -4.49 in FY25
Profit before tax and extraordinary items reached 95.38 for FY26 compared to 52.35 in FY25
Capex on purchase of fixed assets totaled 23.49 during FY26 compared to 18.09 in FY25
Closing cash and cash equivalents increased to 164.48 at the end of FY26 against 64.38 in FY25

💡 Investors should monitor upcoming quarterly results to assess whether working capital improvements and operating cash flow generation remain sustainable.

Unjha Formulations Files FY26 Cash Flow Statement: Operating Cash Flow Turns Positive at 124.38 Lakh

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 14 Aug 2026, 06:38 PM

Unjha Formulations has submitted its audited Cash Flow Statement for FY26 pursuant to its 32nd Annual General Meeting held on August 14, 2026. Operating cash flow improved significantly to positive 124.38 lakh for FY26 from an outflow of 4.49 lakh in FY25, driven by higher operational profitability and working capital adjustments. Capital expenditure on fixed assets stood at 23.49 lakh compared to 18.09 lakh in the previous year. Consequently, closing cash and bank balances increased to 164.48 lakh as of March 31, 2026, compared to 64.38 lakh in FY25.

Net cash inflow from operating activities stood at 124.38 lakh in FY26 vs an outflow of 4.49 lakh in FY25
Capital expenditure via purchase of fixed assets amounted to 23.49 lakh vs 18.09 lakh in FY25
Net increase in cash and cash equivalents totaled 100.10 lakh during FY26
Closing cash and cash equivalents rose to 164.48 lakh as of March 31, 2026, from 64.38 lakh in FY25

💡 Track upcoming Q2 FY27 quarterly financial results to monitor sustaining operating cash generation and revenue growth trends.

Unjha Formulations Q1 Net Profit Drops 59.7% YoY to ₹15.69 Lacs

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 05 Aug 2026, 02:28 PM

Unjha Formulations reported a weak start to FY27, with Q1 revenue declining 9% YoY to ₹3.31 Cr. Net profit saw a significant contraction of 59.7% YoY, falling to ₹15.69 Lacs from ₹38.99 Lacs in the year-ago period. While the company returned to profitability following a ₹74 Lacs loss in the preceding March 2026 quarter, the sharp year-on-year decline in margins is a concern for a micro-cap with a ₹12 Cr market valuation.

Total Income from operations decreased 9% YoY to ₹330.67 Lacs.
Net Profit after tax fell 59.7% YoY to ₹15.69 Lacs compared to ₹38.99 Lacs in June 2025.
Earnings Per Share (EPS) for the quarter stood at ₹0.35, down from ₹0.87 YoY.
The company recovered from a net loss of ₹74 Lacs reported in the previous quarter (March 2026).
Equity Share Capital remains unchanged at ₹448.05 Lacs.

💡 Investors should monitor if the company can restore its quarterly revenue to the ₹4 Cr+ levels seen in late 2025 to regain operating leverage and margin stability.

Unjha Formulations Q1 Results: Net Profit at ₹0.16 Cr, Down 60% YoY; Revenue Declines 9%

🔴 NEGATIVE ⭐ 5/10

EARNINGS 📅 03 Aug 2026, 03:11 PM

Unjha Formulations reported a net profit of ₹15.69 lakhs for Q1 FY27, representing a 59.8% decline from ₹38.99 lakhs in the same quarter last year. Total income fell 9% YoY to ₹3.31 crore, though it showed a marginal recovery from the ₹0.74 crore loss reported in the preceding quarter (Q4 FY26). The company faces significant margin pressure, with raw material costs (₹3.20 crore) accounting for nearly 97% of total income. This micro-cap entity (₹12 Cr market cap) continues to exhibit high volatility in its quarterly bottom line.

Net Profit decreased by 59.8% YoY to ₹15.69 lakhs from ₹38.99 lakhs.
Total Income from operations declined 9% YoY to ₹3.31 crore compared to ₹3.63 crore in Q1 FY26.
Cost of materials consumed stood at ₹3.20 crore, representing 96.7% of total income.
Earnings Per Share (EPS) dropped to ₹0.35 from ₹0.87 in the year-ago period.
The company returned to profit after reporting a net loss of ₹74.28 lakhs in the previous quarter (March 2026).

💡 Investors should monitor the company's ability to manage raw material costs, which currently consume almost the entire revenue base, and watch for any stabilization in quarterly sales volumes.

Unjha Formulations Q1 FY27: Net Profit at ₹0.16 Cr, Recovers from Previous Quarter Loss

🟡 NEUTRAL ⭐ 5/10

EARNINGS 📅 03 Aug 2026, 03:04 PM

Unjha Formulations reported a total income of ₹3.31 Cr for Q1 FY27, representing a 9% decline compared to ₹3.63 Cr in the same quarter last year. The company returned to profitability with a net profit of ₹0.16 Cr, recovering from a significant net loss of ₹0.74 Cr in the preceding March 2026 quarter. Earnings Per Share (EPS) stood at ₹0.35 for the quarter, down from ₹0.87 YoY. The company maintains a debt-free balance sheet but operates at a very small scale with a market capitalization of just ₹12 Cr.

Total income for Q1 FY27 was ₹3.31 Cr, a slight decrease from ₹3.33 Cr in the previous quarter.
Net profit recovered to ₹15.69 Lakhs (₹0.16 Cr) from a loss of ₹74.28 Lakhs in Q4 FY26.
Total expenses were reduced to ₹3.15 Cr, down from ₹3.82 Cr in the previous quarter, largely due to inventory adjustments.
Cost of materials consumed rose to ₹3.20 Cr in Q1 FY27 compared to ₹2.69 Cr in Q1 FY26.
The company remains a single-segment business with no pending investor complaints as of June 30, 2026.

💡 Investors should monitor if the company can sustain this return to profitability and reverse the year-on-year revenue decline in the coming quarters.

Unjha Formulations sets Aug 7 as cut-off date for 32nd AGM e-voting

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 28 Jul 2026, 02:06 PM

Unjha Formulations Ltd has announced the schedule for its 32nd Annual General Meeting (AGM) to be held on August 14, 2026. The company has fixed August 7, 2026, as the cut-off date to determine shareholder eligibility for electronic voting. The e-voting window will be open from August 11, 2026 (09:00 AM) to August 13, 2026 (05:00 PM). This is a standard procedural filing in compliance with Section 108 of the Companies Act, 2013.

32nd Annual General Meeting (AGM) scheduled for August 14, 2026
Cut-off date for e-voting eligibility fixed as August 7, 2026
E-voting period starts on August 11, 2026, at 09:00 AM
E-voting period ends on August 13, 2026, at 05:00 PM
Results to be declared by the Chairman on or after August 14, 2026

💡 Investors should review the full AGM notice once available to understand specific resolutions, such as potential dividends or director appointments, that will be put to vote.

Unjha Formulations to Hold 32nd AGM on August 14, 2026; Releases FY26 Annual Report

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Jul 2026, 02:36 PM

Unjha Formulations Ltd has released its 32nd Annual Report for the financial year 2025-26 and scheduled its Annual General Meeting (AGM) for August 14, 2026. The company, a micro-cap with a market capitalization of approximately ‑12 Cr, reported a TTM revenue of ‑16 Cr and a PAT of ‑1 Cr. This filing is a standard regulatory requirement under SEBI Regulations 30 and 34. Investors should look for detailed management commentary and operational breakdowns within the full report to assess the company's growth trajectory in the pharmaceutical sector.

32nd Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:15 AM
Annual Report released for the financial year ending March 31, 2026
Company maintains a debt-free status with ‑0 Cr debt as per latest financial context
TTM revenue stands at ‑16 Cr against a market capitalization of ‑12 Cr

💡 Investors should review the full Annual Report for disclosures on related-party transactions and management's strategy to improve operating margins, which stood at 6.5% TTM.

Unjha Formulations Ltd Schedules 32nd AGM for August 14, 2026; Releases FY26 Annual Report

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Jul 2026, 02:27 PM

Unjha Formulations Ltd has submitted its 32nd Annual Report for the financial year 2025-26 as per SEBI regulations. The Annual General Meeting (AGM) is scheduled for August 14, 2026, at the company's registered office in Sidhpur. A cut-off date of August 07, 2026, has been established to determine shareholder eligibility for e-voting. This is a standard administrative filing providing the comprehensive audited financial results for the past fiscal year.

32nd Annual Report released for the financial year 2025-26
Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:15 AM
Cut-off date for e-voting eligibility set for August 07, 2026
Company operates with a small market capitalization of Rs 12 Cr and zero debt

💡 Investors should review the full Annual Report for management's discussion on the FY26 performance and any updates on the company's 6.5% operating margins.

Unjha Formulations Ltd Sets AGM for August 2026; Book Closure from August 8-14

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 20 Jul 2026, 02:05 PM

Unjha Formulations Ltd has issued a public notice regarding its upcoming Annual General Meeting (AGM) and associated voting procedures. The company has scheduled the book closure period from August 8, 2026, to August 14, 2026, to determine shareholder eligibility for the financial year ended March 31, 2026. Remote e-voting will be available for three days, starting August 11 and ending August 13, 2026. This is a standard regulatory compliance filing with no direct impact on business operations or financial performance.

Book closure period scheduled from August 8, 2026, to August 14, 2026
Remote e-voting window opens on August 11, 2026, at 9:00 a.m.
Remote e-voting window closes on August 13, 2026, at 5:00 p.m.
Cut-off date for determining voting eligibility is August 7, 2026

💡 Shareholders should ensure their holdings are updated by the August 7, 2026, cut-off date if they wish to participate in the e-voting process for AGM resolutions.

Unjha Formulations to Hold 32nd AGM on August 14, 2026; Cut-off Date August 07

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 16 Jul 2026, 02:02 PM

Unjha Formulations Ltd has scheduled its 32nd Annual General Meeting (AGM) for August 14, 2026, at 10:15 AM. The company has fixed August 07, 2026, as the cut-off date to determine shareholder eligibility for remote e-voting and voting during the meeting. This is a standard regulatory filing in compliance with SEBI (LODR) Regulations, 2015. No specific financial results or corporate actions were disclosed in this notice.

32nd Annual General Meeting scheduled for August 14, 2026
Cut-off date for e-voting eligibility set for August 07, 2026
Meeting to be held at 10:15 AM at the Registered Office in Sidhpur, Gujarat
Notice issued pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

💡 Investors should monitor for the full Annual Report to review the company's financial performance and any proposed resolutions before the voting cut-off on August 07.

Board Meeting on August 3, 2026, to Approve Q1 FY27 Financial Results

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 16 Jul 2026, 01:58 PM

Unjha Formulations Ltd has scheduled a board meeting for August 3, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026. This is a routine regulatory filing as per SEBI (LODR) Regulations. The meeting is set to take place at the company's registered office in Sidhpur, Gujarat, at 2:15 PM. Investors should note that financial data for the trailing twelve months is currently not disclosed in the provided context.

Board meeting scheduled for August 3, 2026, to review Q1 FY27 results
Financial results pertain to the quarter ended June 30, 2026
Meeting is scheduled to commence at 14:15 (2:15 PM) IST
Compliance filing under Regulation 29(1)(a) of SEBI LODR

💡 Monitor the BSE website on August 3, 2026, for the release of the financial results to assess the company's revenue and profitability trends.

Unjha Formulations Ltd Publishes Newspaper Notice for 32nd Annual General Meeting

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 15 Jul 2026, 03:57 PM

Unjha Formulations Limited has submitted copies of newspaper advertisements regarding its 32nd Annual General Meeting (AGM). The notices were published in Free Press (English) and Lok Mitra (Gujarati) as per regulatory requirements. The document specifies the AGM date as July 14, 2026. This filing is a standard procedural compliance under SEBI (LODR) Regulations and does not contain new financial data.

32nd Annual General Meeting (AGM) notice issued to shareholders.
Notice published in two newspapers: Free Press (English) and Lok Mitra (Gujarati).
AGM date cited in the document as July 14, 2026.
Filing submitted to the exchange on July 15, 2026.

💡 Investors should review the company's Annual Report for the relevant financial year to assess operational performance and management's future outlook.

Unjha Formulations to hold 32nd Annual General Meeting on August 14, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 15 Jul 2026, 03:43 PM

Unjha Formulations Ltd has issued newspaper advertisements regarding its 32nd Annual General Meeting (AGM). The meeting is scheduled to be held on August 14, 2026, as per the exchange brief. The advertisements were published in Free Press (English) and Lok Mitra (Gujarati) on July 14, 2026. This is a standard regulatory compliance filing for listed companies.

32nd Annual General Meeting scheduled for August 14, 2026
Notices published in 2 newspapers: Free Press and Lok Mitra
Announcement submitted to the exchange on July 15, 2026
Newspaper publication date recorded as July 14, 2026

💡 Investors should monitor for the release of the full Annual Report to review the company's financial performance and management's outlook for the pharmaceutical business.

View All 531762 Announcements on Live Market Tracking →